Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
FDA-watchers say the most likely outcome may be a temporary policy reassuring pharmacies that they wont be targeted for compounding the peptides under review
AOD-9604 was originally developed as a potential anti-obesity drug due to its ability to promote fat loss without significantly impacting muscle growth or insulin levels
Plan on continuing it
Animal-model evidence consistently shows local effects: angiogenesis at the injury site (VEGF upregulation), growth-factor signaling (EGF, FGF), nitric oxide pathway modulation, and accelerated tendon-to-bone interface healing in rat Achilles transection studies
US$ 23.43
US$ 23.93
US$ 26.37
US$ 20.74
US$ 24.30
US$ 28.41
